After NeuroMetrix (NURO ) (NURO) received inquiries about its marketing tactics, rumors of possible federal indictments pummeled the stock. In a Sept. 19 report, William Quirk of RBC Capital Markets (RY ) added: "Concerns are largely based on false information." Quirk says the stock is worth 50. There's fear in the market about the stock, says David Turkaly of Susquehanna Financial Group. Note: Unless otherwise noted, neither the sources cited in Inside Wall Street nor their firms hold ...
Click Here to View the Entire Article “ Concerns are largely based on false information. ”
